Search
for
Sort by
Research 241–270 of 1000+
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Tofacitinib for the treatment of lichen planopilaris: A case series
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alopecia Areata: Current Treatments and New Directions
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Inhibiting Janus kinases to treat alopecia areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Treatment of pediatric alopecia areata: A systematic review
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- New and Emerging Therapies for Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- Review of treatment for alopecia totalis and alopecia universalis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Tofacitinib therapy for children with severe alopecia areata
- Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Ruxolitinib for the treatment of severe alopecia areata
- The Diagnosis and Treatment of Hair and Scalp Diseases
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience